Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Retained Earnings (2010 - 2026)

Vericel (VCEL) posted Retained Earnings of -$380.4 million for Q2 2026, up 0.58% sequentially from -$382.6 million in Q1 2026, and up 5.98% YoY from -$358.9 million in Q2 2025.

Analysis

Vericel (VCEL) Retained Earnings (2010 - 2026) Analysis & Trends

Vericel has reported Retained Earnings for 17 years, with the latest figure at -$380.4 million in Q2 2026.

  • Quarterly Retained Earnings rose 5.98% year-over-year to -$380.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$380.4 million (up 5.98% YoY) and the FY2025 annual result came in at -$376.3 million, up 4.21% from the prior year.
  • Retained Earnings climbed to -$380.4 million in Q2 2026 per VCEL's latest filing, from -$382.6 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$376.3 million in Q4 2025 and troughed at -$416.2 million in Q3 2023.
  • A 5-year average of -$400.4 million and a median of -$403.6 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2022 and 2026: Retained Earnings declined 4.67% in 2022, then gained 5.98% in 2026.
  • Over 5 years, Retained Earnings stood at -$400.0 million in 2022, then slipped by 0.8% to -$403.2 million in 2023, then advanced by 2.57% to -$392.8 million in 2024, then increased by 4.21% to -$376.3 million in 2025, then fell by 1.09% to -$380.4 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$380.4 million, -$382.6 million, and -$376.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn -380.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -380.40 Mn
Mar 31, 2026 -382.60 Mn
Dec 31, 2025 -376.30 Mn
Sep 30, 2025 -399.54 Mn
Jun 30, 2025 -404.61 Mn
Mar 31, 2025 -404.10 Mn
Dec 31, 2024 -392.82 Mn
Sep 30, 2024 -412.62 Mn
Jun 30, 2024 -411.72 Mn
Mar 31, 2024 -407.04 Mn
Dec 31, 2023 -403.18 Mn
Sep 30, 2023 -416.20 Mn
Jun 30, 2023 -412.51 Mn
Mar 31, 2023 -407.50 Mn
Dec 31, 2022 -400.00 Mn
Sep 30, 2022 -405.92 Mn
Jun 30, 2022 -399.34 Mn
Mar 31, 2022 -390.40 Mn
Dec 31, 2021 -383.29 Mn
Sep 30, 2021 -387.82 Mn